US · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Electromedical Technologies, Inc. EMED
5 fiscal years on record · USD · FY2023 reported
SEC FILINGS ONLY
Revenue · FY2023
$1.3M
▲ 17.3% vs FY2022
EPS · FY23
$0.00
Dividend / sh · FY23
—
Payout · FY23
—
ROE · FY23
—
Net margin · FY23
-195.8%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.3M
Revenue, FY2023 · full 5-year series below
Revenue
Net income
The company lost 196 cents on every revenue dollar this year.
Per share
USD 0.00
Diluted EPS, FY2023
EPS
The company pays no cash dividend.
Profitability
—
Return on equity, FY2023
ROE
Operating margin-153.1%
Net margin-195.8%
Return on assets-251.3%
Returned to shareholders
—
returned in FY2023 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+22.3%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.46B
Shares outstanding, FY2023
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 748,383.00
total assets, end of FY2023
Total assetsUSD 748,383.00
EquityUSD -2.9M
CashUSD 87,704.00
Gross debtUSD 150,000.00
Net debtUSD 62,296.00
Current ratio0.13×
Net debt stands at -2% of equity.
History
5 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2023
2022
2021
2020
2019
Revenue $B
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
·
·
·
·
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
0.00
−0.03
−0.24
−0.20
−0.10
Dividend / sh $
·
·
·
·
·
Payout %
·
·
·
·
·
ROE %
·
·
·
·
·
Shares out B
0.46
0.19
0.09
0.03
0.02
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
19 of 19
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed